MentionFox
Home › funding signals › Nuntius Therapeutics
Accelerator · announced

Nuntius Therapeutics (YC W21) — Cell-specific genetic medicines

Nuntius Therapeutics appears in Y Combinator's company directory in the Winter 2021 batch, listed 2021-03-01. Cell-specific genetic medicines.

Just raised? Share it.

Nuntius Therapeutics: Accepted into Y Combinator Winter 2021

What do you want to do with Nuntius Therapeutics?

Nuntius Therapeutics

New accelerator entry · 2021-03-01 · the record

Winter 2021
batch
2
people
Early
stage
United Kingdom
region
Open the record →

What the record says

BatchWinter 2021
Announced2021-03-01
StageEarly
StatusActive
Team size2
IndustryHealthcare
Sub-industryHealthcare -> Therapeutics
SectorsGene Therapy, Nanomedicine
RegionsUnited Kingdom, Europe, Remote, Partly Remote
BasedLondon, England, United Kingdom
HiringNo
Sitehttp://www.nuntiustx.com

The full profile

Checking your access…

Is this you?

If you're behind Nuntius Therapeutics: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

Tools for this story

Each opens in a new tab, filled in for Nuntius Therapeutics. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-nuntius-therapeutics
Last updated 2026-09-26
Primary record: Y Combinator directory entry
Nuntius Therapeutics (YC W21) — Cell-specific genetic medicines. MentionFox, 2026-09-26. https://mentionfox.com/funding/yc-nuntius-therapeutics